Further studies will, however, be required to assess the effects of elevated PAPP-A concentrations on autocrine and paracrine mechanisms for the exacerbation of atherosclerosis procession and plaque rupture through IGFBP-4 cleavage and enhanced local IGF-I bioavailability. The gene discussed is PAPPA; the disease is atherosclerosis.